Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00622453 · ClinicalTrials.gov registry record

Arrhythmias in Myotonic Muscular Dystrophy

A clinical trial of Arrhythmia and Muscular Dystrophy, sponsored by Indiana University School of Medicine.

Completed
Registry status
448
Enrollment target
1
Study location

NCT00622453 is a study of Arrhythmia and Muscular Dystrophy that has completed, run by Indiana University School of Medicine. The registered enrollment target is 448 participants, below the 1,861-participant average among 16 other Arrhythmia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00622453, a study of Arrhythmia and Muscular Dystrophy, has completed, sponsored by Indiana University School of Medicine.

COMPLETED
Registry status
448 participants
Enrollment target
1
Study location

Study Summary

Adult myotonic muscular dystrophy (Steinert's disease) is the most common inherited neuromuscular disorder. Cardiac rhythm disturbances occur frequently in this disease state and may be responsible for up to one-third of deaths. In this study, we intend to evaluate the utility of non-invasive electrocardiographic screening methods and history in predicting serious arrhythmic events.

Interventions

  • OTHER Screening

Study Locations (1)

Indiana

  • Krannert Institute of Cardiology - Indianapolis

Trial Details

FieldValue
Enrollment Target 448 participants
Start Date 1996-09
Est. Completion 2015-02

What the Registry Record Tells You About NCT00622453

The ClinicalTrials.gov registry entry for NCT00622453 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 448 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,861-participant average among 16 other Arrhythmia trials with a reported enrollment target (76% lower). The listed sponsor is Indiana University School of Medicine, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which Screening is the first listed.

NCT00622453 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT00622453 about?

NCT00622453 is a clinical study titled "Arrhythmias in Myotonic Muscular Dystrophy". Adult myotonic muscular dystrophy (Steinert's disease) is the most common inherited neuromuscular disorder. Cardiac rhythm disturbances occur frequently in this disease state and may be responsible for up to one-third of deaths. In this study, we intend to evaluate the utility of non-invasive electr...

What is the current status of trial NCT00622453?

This trial is currently completed. The enrollment target is 448 participants. The study started on 1996-09. Estimated completion is 2015-02.

What conditions does trial NCT00622453 study?

This clinical trial studies the following conditions: Arrhythmia, Muscular Dystrophy, Sudden Cardiac Death.

What interventions are being tested in trial NCT00622453?

The interventions under investigation include: Screening (OTHER).

Who is sponsoring clinical trial NCT00622453?

This trial is sponsored by Indiana University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00622453 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.